Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 1

Status

Completed 3

Sponsor Class

NETWORK 3OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Lymphoma 12Hodgkin Disease 11Urinary Bladder Neoplasms 7Urethral Neoplasms 3Melanoma 2Uterine Cervical Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neurofibromatosis 1 1Neuroectodermal Tumors, Primitive, Peripheral 1Lymphoma, Large-Cell, Anaplastic 1Lung Neoplasms 1HIV Infections 1Desmoid Tumors 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Astrocytoma 1

Interventions

Gemcitabine 9Paclitaxel 7Carboplatin 5Cisplatin 4Vinblastine 3Methotrexate 3Doxorubicin 2rubitecan 1romidepsin 1piritrexim 1lonafarnib 1Surgical Procedures, Operative 1Radiotherapy 1Pemetrexed 1Neoadjuvant Therapy 1Irinotecan 1Gefitinib 1Docetaxel 1Depsipeptides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Urethral Neoplasms × Vinblastine × Clear all
NCT00003376 2023-06-22

Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium

Eastern Cooperative Oncology Group

Phase 3 Completed
330 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00003701 2023-06-15

Combination Chemotherapy in Treating Patients With Bladder Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
490 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00014274 2013-06-12

Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Completed
238 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡